scanX
Bandaram Pharma Packtech
24.78
+1.85(+8.07%)
Market Cap₹44.52 Cr
PE Ratio91.72
IndustryHealthcare Services
Company Performance:
1D+8.07%
1M-9.99%
6M-19.39%
1Y-38.31%
5Y+8.54%
View Company Insightsright
Latest news about Bandaram Pharma Packtech
Bandaram Pharma Packtech Adjusts Subsidiary's Textbook Order Value to Rs 27.71 Crore from Rs 37.44 Crore Jun 11, 2026
Bandaram Pharma Packtech has revised its subsidiary's textbook order value to Rs 27.71 crore, down from the earlier figure of Rs 37.44 crore. The announcement reflects a downward adjustment in the order, with no further details on the reasons for the change currently available.
no imag found
Bandaram Pharma Packtech director NSK Aakarsh Raj resigns Jun 05, 2026
no imag found
Bandaram Pharma reports FY26 profit, auditors flag subsidiary issues May 31, 2026
no imag found
no imag found
Bandaram unit secures Rs 3.87 crore order for textbook materials May 29, 2026
no imag found
Bandaram board to meet on May 30 to consider FY26 results May 21, 2026
More news about Bandaram Pharma Packtech
11Apr 26
Bandaram Pharma Packtech Limited Submits Q4FY26 Compliance Certificate Under SEBI Regulations
Bandaram Pharma Packtech Limited submitted its Q4FY26 compliance certificate under SEBI Regulation 74(5) to BSE Limited on 11.04.2026. The certificate, issued by RTA Cameo Corporate Services Limited, confirms proper processing of dematerialisation requests, certificate mutilation procedures, and timely register updates for the quarter ended 31.03.2026.
no imag found
03Apr 26
Bandaram Pharma Packtech Submits EGM Notice Under Regulation 30 for April 27
Bandaram Pharma Packtech has formally submitted its EGM notice to BSE under Regulation 30, scheduling the meeting for April 27, 2026. The agenda includes appointing Mr. Eswar Reddy Putturu as Independent Director and approving material related party transactions worth ₹100 crores with subsidiary VSR Paper and Packaging Limited, comprising ₹50 crores for sales/purchase and ₹50 crores for corporate guarantee.
no imag found
13Feb 26
Bandaram Pharma Packtech Announces Q3FY26 Results Under Regulation 33 Compliance
Bandaram Pharma Packtech Limited announced its Q3FY26 financial results under SEBI Regulation 33 compliance, showing contrasting performance between standalone and consolidated operations. While standalone operations reported a net loss of Rs. 21.14 lakhs, consolidated operations achieved a net profit of Rs. 34.95 lakhs, primarily driven by subsidiary performance including VSR Paper & Packaging Limited and Craftsmart Products Private Limited.
no imag found
30Jan 26
Bandaram Pharma Packtech Limited Announces Board Changes with New Director Appointment and Resignation
Bandaram Pharma Packtech Limited announced board changes effective 30.01.2026, appointing Mr. Eswar Reddy Putturu as Additional Non-Executive Independent Director for a 5-year term and accepting Mrs. Priyanka Agarwal's resignation due to personal reasons. The new director brings MBA expertise in finance and marketing, while the outgoing director also served on boards of Midland Polymers Limited and Cura Technologies Limited. All regulatory compliance requirements under SEBI regulations have been fulfilled.
no imag found
14Nov 25
Bandaram Pharma Packtech Reports Q2 FY26 Loss of Rs. 34.74 Lakhs Amid Revenue Decline
Bandaram Pharma Packtech Limited reported a net loss of Rs. 34.74 lakhs for Q2 FY26, compared to a profit of Rs. 67.19 lakhs in Q2 FY25. Standalone revenue fell by 89.6% to Rs. 32.93 lakhs. Despite reducing expenses by 75.8%, the company couldn't offset the revenue decline. Half-yearly results show a total income of Rs. 109.50 lakhs and a net loss of Rs. 61.63 lakhs. Consolidated performance was slightly better with revenue of Rs. 1,372.48 lakhs and a net profit of Rs. 6.02 lakhs for Q2 FY26.
no imag found
07Nov 25
Bandaram Pharma Packtech Promoters Acquire Additional Shares Through Preferential Allotment
Bandaram Pharma Packtech Limited announced a major share acquisition by its promoters. Prajitha Bandaram acquired 486,480 shares through preferential allotment on November 6, 2025. This increased the company's equity share capital from Rs. 12.00 crores to Rs. 17.97 crores. After the acquisition, the promoter group's holdings include Prajitha Bandaram (486,480 shares), Satyavathi Bandaram (1,880,000 shares), B Premsai Reddy (1,880,000 shares), and M. Seetharama Reddy (112,500 shares). The disclosure was filed under SEBI regulations for substantial acquisition of shares and takeovers.
no imag found
05Sept 25
Bandaram Pharma Packtech Reappoints Chairman, Sets AGM Date for September 2025
Bandaram Pharma Packtech's board has approved the reappointment of Mr. Deepak Reddy Bandaram as Chairman and Managing Director for three years, subject to shareholder approval. The company's AGM for FY 2024-25 is scheduled for September 29, 2025, via video conference. The board also approved the Directors' Report for FY 2024-25.
no imag found
Bandaram Pharma Packtech
24.78
+1.85
(+8.07%)
1 Year Returns:-38.31%
Industry Peers
Dr. Lal Path Labs
1,692.80
(+0.49%)
Vijaya Diagnostic Centre
1,389.10
(+0.82%)
Metropolis Healthcare
567.95
(+1.41%)
Thyrocare Technologies
515.70
(-3.71%)
Nephrocare Health Services
649.00
(+2.46%)
Krsnaa Diagnostics
556.65
(-0.04%)
Suraksha Diagnostic
264.30
(+0.34%)
One Global Service Provider
610.00
(-1.29%)
Health X Platform
323.30
(-1.93%)
3B BlackBio DX
1,148.60
(-1.64%)

Get More Market Insights with

insight.name
Heatmap
insight.name
FII/DII
insight.name
Company Filings
insight.name
MF Holdings
insight.name
Bulk/ Block Deals
insight.name
Stock Rental via SLBM
insight.name
Signals
insight.name
MTF Insights
insight.name
F&O Ban - MWPL
insight.name
Top Deliveries
insight.name
Market Valuation
insight.name
IPO
insight.name
Cyclical Trend
insight.name
Events Calendar
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104